Abstract
During the pandemic, Remdesivir was approved as a treatment for severe COVID-19. Little is known about its adverse side effects, as it had not been in clinical use prior to the pandemic, and we continue to learn more daily about its impact-both positive and negative-on our patients. In this case report, we present a patient who developed sinus bradycardia on the third day of Remdesivir administration, NSVT on the fifth day of Remdesivir, and whose arrhythmias resolved after cessation of Remdesivir.
Highlights
Remdesivir was approved as a treatment for severe COVID-19
We present a patient who developed sinus bradycardia on the third day of Remdesivir administration, NSVT on the fifth day of Remdesivir, and whose arrhythmias resolved after cessation of Remdesivir
COVID-19 emerged to an unsuspecting world in late 2019 and by early 2020 the disease was so widespread that it was declared a pandemic by the World Health Organization
Summary
COVID-19 emerged to an unsuspecting world in late 2019 and by early 2020 the disease was so widespread that it was declared a pandemic by the World Health Organization. We report a case of an elderly male who developed symptoms 11 days after his positive COVID test, and who experienced arrhythmias while on Remdesivir. The patient incidentally tested positive for COVID-19 on December 26, 2020 and was asymptomatic throughout his quarantine at home He was released from quarantine by the health department after 10 days. Patient was noted to have had multiple stress tests in the past, all of which were negative Given that he was asymptomatic, with no troponin elevation, no ischemic changes on EKG and no acute findings on echo, we did not pursue a stress test or catheterization. He was observed on telemetry, and no further episodes were noted.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
